Related Experiment Video
Updated: May 30, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
EULAR recommendations for vaccination in paediatric patients with rheumatic diseases
M W Heijstek1, L M Ott de Bruin, M Bijl
1Department of Paediatric Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Room KC 03.063.0, PO Box 85090, 3508 AB Utrecht, The Netherlands. m.w.heijstek@umcutrecht.nl
Vaccination guidelines for children with rheumatic diseases (PaedRD) were established using EULAR procedures. Further research is needed on vaccine safety and effectiveness in this vulnerable pediatric population.
Area of Science:
- Rheumatology
- Immunology
- Vaccinology
- Public Health
Background:
- Paediatric patients with rheumatic diseases (PaedRD) are at increased risk of infections.
- Standardized vaccination protocols are crucial for managing this population.
- Existing guidelines require updates based on current evidence.
Purpose of the Study:
- To develop evidence-based vaccination recommendations for paediatric patients with rheumatic diseases (PaedRD).
- To synthesize current literature on vaccine safety and efficacy in this cohort.
- To identify research gaps in paediatric rheumatology vaccination.
Main Methods:
- Systematic literature review of MEDLINE, EMBASE, and major rheumatology conference abstracts (2008/9).
- EULAR (European Alliance of Associations for Rheumatology) standardised guideline development procedures.
- Delphi voting by a multidisciplinary task force to achieve consensus.
Main Results:
- Fifteen recommendations for vaccination in PaedRD were developed with 91.7% overall agreement.
- Literature primarily focused on seasonal influenza and pneumococcal vaccines.
- Limited studies specifically addressed paediatric populations, with a focus on adult rheumatoid arthritis and systemic lupus erythematosus.
Conclusions:
- Evidence-based vaccination recommendations for PaedRD have been established.
- Significant research gaps exist regarding the safety and immunogenicity of vaccinations, especially live-attenuated vaccines and in patients on biologicals.
- Further investigation is required to understand the impact of vaccination on infection prevention in PaedRD.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Respiratory Syncytial Virus Disease
Vaccinations
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease I: Introduction